ResearcherSecond Military Medical UniversityNo recent work listed

Qian‐Zhi Ni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4659-7696; OpenAlex author ID A5084836202. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. Co-author DOI 10.1002/advs.202202448 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiao‐Fan Wang · 1 shared paper, 2023 · strength 0.12
- Paper PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of… DOI 10.1002/advs.202202448 ↗
Wentao Zhou · 1 shared paper, 2023 · strength 0.12
- Paper PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of… DOI 10.1002/advs.202202448 ↗
Wei Chen · 1 shared paper, 2023 · strength 0.12
- Paper PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of… DOI 10.1002/advs.202202448 ↗
Jing‐Jing Li · 1 shared paper, 2023 · strength 0.12
- Paper PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of… DOI 10.1002/advs.202202448 ↗
Shuqun Cheng · 1 shared paper, 2023 · strength 0.12
- Paper PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of… DOI 10.1002/advs.202202448 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.